Botanical species · safety record

Chiococca alba

The EFSA Compendium of Botanicals holds 5 constituent measurements and 8 adverse-effect records for Chiococca alba. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Chiococca alba (L.) Hitchc.

5Constituent measurements
8Safety records
5Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Chiococcasaponins1
  • Coumarins1
  • Matairesinol1
  • Merilactone1
  • Quinoline alkaloids1

Plant parts

  • Roots and other underground parts10
  • Leaves2

Preparations

  • Solvent extraction12

Effect types

  • Hepatotoxicity2
  • Irritation2
  • Nephrotoxicity2
  • Neurotoxicity2

Target tissues

  • Digestive2
  • Liver2
  • Neurologic2
  • Urogenital: kidneys2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
ChiococcasaponinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
MerilactoneRoots and other underground partsSolvent extractionResolve DOI
CoumarinsLeavesSolvent extractionChromatographic testsNo resolvable identifier
MatairesinolLeavesSolvent extractionChromatographic testsNo resolvable identifier
Quinoline alkaloidsNuclear Magnetic Resonance (NMR)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityLiverRoots and other underground partsSolvent extractionHouse mouse (as animal)Acute toxicityResolve DOI
HepatotoxicityLiverRoots and other underground partsSolvent extractionHouse mouse (as animal)Acute toxicityResolve DOI
IrritationDigestiveRoots and other underground partsSolvent extractionHouse mouse (as animal)Acute toxicityResolve DOI
IrritationDigestiveRoots and other underground partsSolvent extractionHouse mouse (as animal)Acute toxicityResolve DOI
NephrotoxicityUrogenital: kidneysRoots and other underground partsSolvent extractionHouse mouse (as animal)Acute toxicityResolve DOI
NephrotoxicityUrogenital: kidneysRoots and other underground partsSolvent extractionHouse mouse (as animal)Acute toxicityResolve DOI
NeurotoxicityNeurologicRoots and other underground partsSolvent extractionHouse mouse (as animal)Short-term toxicityResolve DOI
NeurotoxicityNeurologicRoots and other underground partsSolvent extractionHouse mouse (as animal)Short-term toxicityResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Gazda, VE., Gomes-Carneiro, MR., Barbi, NS., Paumgartten, FJR. Toxicological evaluation of an ethanolic extract from Chiococca alba roots. JOURNAL OF ETHNOPHARMACOLOGY, 2006, vol. 105, no. 1-2, p. 187-195. DOI
  2. Borges, Ricardo Moreira., Valenca, Samuel Santos., Lopes, Alan Aguiar., Barbi, Nancy dos Santos., Ribeiro da Silva, Antonio Jorge. Saponins from the roots of Chiococca alba and their in vitro anti-inflammatory activity. PHYTOCHEMISTRY LETTERS, 2013, vol. 6, no. 1, p. 96-100. DOI
  3. ELHAFIZ, MAA., WENIGER, B., QUIRION, JC., ANTON, R. KETOALCOHOLS, LIGNANS AND COUMARINS FROM CHIOCOCCA-ALBA. PHYTOCHEMISTRY, 1991, vol. 30, no. 6, p. 2029-2031.
  4. KITAHARA, Y., SHIMIZU, M., KUBO, A. SYNTHESIS OF NEW QUINOLINE ALKALOIDS OF CHIOCOCCA-ALBA. HETEROCYCLES, 1990, vol. 31, no. 11, p. 2085-2090.
  5. Borges-Argaez, R., Medina-Baizabal, L., May-Pat, F., Waterman, PG., Pena-Rodriguez, LM. Merilactone, an unusual C-19 metabolite from the root extract of Chiococca alba. JOURNAL OF NATURAL PRODUCTS, 2001, vol. 64, no. 2, p. 228-231. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue